Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04965753
Title FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Foghorn Therapeutics Inc.
Indications
Therapies
Age Groups: senior | child | adult
Covered Countries USA | ITA | FRA | ESP

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of Miami Health System Miami Florida 33136 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37205 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
Centre Leon Berard Lyon 69008 France Details
Institut Gustave Roussy Villejuif 94805 France Details
Istituto Nazionale dei Tumori Milan 20133 Italy Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field